This week's big news is that an AI system tested thousands of drug combinations and found one that could keep lung capacity at 98.3% — a result that gives real hope for slowing IPF (the lung-scarring disease) much more effectively than today's treatments.
FVC = how much air your lungs can push out. Higher % = healthier lungs. A typical IPF patient starts around 50–60%.
This is a computer model result — not a prescription. Always talk to your doctor before changing anything.
Researchers are working hard on IPF (a disease where the lungs slowly fill with scar tissue, making it harder to breathe). This week, the database tracking this work grew to over 7,200 studies and nearly 1,800 clinical trials (real tests on people). That is a lot of people around the world trying to find answers for you.
An AI tested drug combinations and found one that kept FVC (forced vital capacity — basically how much air your lungs can hold and push out) at 98.3%. Healthy lungs sit at 100%, so 98.3% is remarkably close to normal. The seven drugs in that mix target scarring, inflammation, and lung cell repair in ways that today's approved drugs do not fully address.
One question to ask your lung doctor at your next visit: "Are there any combination therapy trials open right now that I might qualify for, given where my lung function stands today?"